JP2008514557A5 - - Google Patents

Download PDF

Info

Publication number
JP2008514557A5
JP2008514557A5 JP2007532772A JP2007532772A JP2008514557A5 JP 2008514557 A5 JP2008514557 A5 JP 2008514557A5 JP 2007532772 A JP2007532772 A JP 2007532772A JP 2007532772 A JP2007532772 A JP 2007532772A JP 2008514557 A5 JP2008514557 A5 JP 2008514557A5
Authority
JP
Japan
Prior art keywords
allergen
use according
metal salt
group
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007532772A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008514557A (ja
JP4976298B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2005/000601 external-priority patent/WO2006034707A1/en
Publication of JP2008514557A publication Critical patent/JP2008514557A/ja
Publication of JP2008514557A5 publication Critical patent/JP2008514557A5/ja
Application granted granted Critical
Publication of JP4976298B2 publication Critical patent/JP4976298B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007532772A 2004-09-27 2005-09-22 口腔粘膜投与用液体アレルギーワクチンの配合物 Expired - Fee Related JP4976298B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61389204P 2004-09-27 2004-09-27
US60/613,892 2004-09-27
DKPA200401468 2004-09-27
DKPA200401468 2004-09-27
PCT/DK2005/000601 WO2006034707A1 (en) 2004-09-27 2005-09-22 Liquid allergy vaccine formulation for oromucosal administration

Publications (3)

Publication Number Publication Date
JP2008514557A JP2008514557A (ja) 2008-05-08
JP2008514557A5 true JP2008514557A5 (enExample) 2008-12-25
JP4976298B2 JP4976298B2 (ja) 2012-07-18

Family

ID=35431828

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532772A Expired - Fee Related JP4976298B2 (ja) 2004-09-27 2005-09-22 口腔粘膜投与用液体アレルギーワクチンの配合物

Country Status (16)

Country Link
US (1) US20060115499A1 (enExample)
EP (1) EP1793853B1 (enExample)
JP (1) JP4976298B2 (enExample)
KR (1) KR20070057963A (enExample)
CN (1) CN101048176B (enExample)
AT (1) ATE421330T1 (enExample)
AU (1) AU2005289193A1 (enExample)
CA (1) CA2581815A1 (enExample)
DE (1) DE602005012522D1 (enExample)
DK (1) DK1793853T3 (enExample)
ES (1) ES2321425T3 (enExample)
IL (1) IL182135A0 (enExample)
MX (1) MX2007003609A (enExample)
NO (1) NO20071636L (enExample)
RU (1) RU2007115920A (enExample)
WO (1) WO2006034707A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006310881B2 (en) * 2005-11-04 2012-07-19 Alk-Abello A/S Use of a liquid allergy vaccine formulation for oromucosal administration
ES2370043T3 (es) * 2007-03-28 2011-12-12 Alk-Abelló A/S Uso de una formulación de vacuna de la alergia coadyuvada para administración subcutánea.
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
CA2739557A1 (en) * 2008-10-15 2010-04-22 Alk-Abello A/S Pharmaceutical product for up-dosing of allergy vaccine
US9545455B2 (en) * 2009-04-29 2017-01-17 Pravin K. Muniyappa Device and method for the diagnosis of gastrointestinal allergy
CN106421775B (zh) * 2015-08-12 2020-12-01 普莱柯生物工程股份有限公司 一种疫苗用佐剂及含该佐剂的疫苗组合物和其应用
BR102017026619A2 (pt) 2017-02-15 2018-10-30 Euroimmun Medizinische Labordiagnostika Ag ensaio melhorado para a diagnose de alergia a amendoim

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148121A (en) * 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole inhalant complex and method of making same
US3329564A (en) * 1965-06-28 1967-07-04 Parke Davis & Co Antacid preparations and means of producing the same
US4233288A (en) * 1979-03-12 1980-11-11 Cornell John A Gum emulsified liquid package for delivering and preserving liquid content in the mouth
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
JPS61238728A (ja) * 1985-04-16 1986-10-24 Mitsui Norin Kk 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体
US6103243A (en) * 1985-05-15 2000-08-15 Biotechnology Australia Pty, Ltd Oral vaccines
KR900701304A (ko) * 1988-05-05 1990-12-01 루이즈 츄이 콜린스 에이미 사람 및/또는 동물용 알레르겐 탈감작제
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
US5985312A (en) * 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
CN1338947B (zh) * 1999-02-05 2012-11-14 爱尔开-阿贝优公司 粘膜递送系统
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020051794A1 (en) * 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
KR100919914B1 (ko) * 2000-11-16 2009-10-06 알크-아벨로 에이/에스 신규한 돌연변이체 알레르겐
WO2003096869A2 (en) * 2002-05-16 2003-11-27 Alk Abelló A/S Recombinant bet. v. 1. allergen mutants, methods and process thereof
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.

Similar Documents

Publication Publication Date Title
Shadnia et al. Unintentional poisoning by phosphine released from aluminum phosphide
JP2005500357A5 (enExample)
JP2006505587A5 (enExample)
JP2004538303A5 (enExample)
JP2010518122A5 (enExample)
JP2008526757A5 (enExample)
JP2004512328A5 (enExample)
RU2005135016A (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
JP2005524648A5 (enExample)
JP2009280627A5 (enExample)
JP2009537246A5 (enExample)
CA2540174A1 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
JP2014521658A5 (enExample)
ATE493982T1 (de) Pharmazeutische zusammensetzung enthaltend sns- 595 und deren verwendungen
EP3848369A1 (en) N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
JP2010521516A5 (enExample)
WO2007064658A3 (en) Safe and effective methods of administering therapeutic agents
JP2006506345A5 (enExample)
JP2008514557A5 (enExample)
JP2009541387A5 (enExample)
JP2012508256A5 (enExample)
JP2008501036A5 (enExample)
JP2005511582A5 (enExample)
JP2002537232A5 (enExample)
RU2007115920A (ru) Жидкий противоаллергический вакцинный состав для введения на слизистую оболочку полости рта